These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24045373)

  • 1. Prevalence and control of hypercholesterolaemia as defined by NCEP-ATPIII guidelines and predictors of LDL-C goal attainment in a multi-ethnic Asian population.
    Khoo CM; Tan ML; Wu Y; Wai DC; Subramaniam T; Tai ES; Lee J
    Ann Acad Med Singap; 2013 Aug; 42(8):379-87. PubMed ID: 24045373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.
    Kim HS; Wu Y; Lin SJ; Deerochanawong C; Zambahari R; Zhao L; Zhang Q; Yan P
    Curr Med Res Opin; 2008 Jul; 24(7):1951-63. PubMed ID: 18547466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.
    Park JE; Chiang CE; Munawar M; Pham GK; Sukonthasarn A; Aquino AR; Khoo KL; Chan HW
    Eur J Prev Cardiol; 2012 Aug; 19(4):781-94. PubMed ID: 21450606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.
    Ho KT; Chin KW; Ng KS; Alemao E; Rajagopalan S; Yin D
    Am J Cardiovasc Drugs; 2006; 6(6):383-91. PubMed ID: 17192128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands.
    Heintjes EM; Anastassopoulou A; Kuiper J; Bilitou A; Beest FJAP; Herings RMC; Postma MJ; Jukema JW
    Curr Med Res Opin; 2023 Jan; 39(1):1-11. PubMed ID: 36168818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and ethnic differences in the control of hyperlipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study.
    Rapeport N; Schamroth CL; Blom DJ
    Cardiovasc J Afr; 2013 Jul; 24(6):238-42. PubMed ID: 24217264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.
    Kristensen MS; Green A; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Larsen ML; Ersbøll AK
    BMC Cardiovasc Disord; 2020 Jul; 20(1):336. PubMed ID: 32660429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study.
    Fang HSA; Gao Q; Lee ML; Hsu W; Tan NC
    Lipids Health Dis; 2021 Jan; 20(1):2. PubMed ID: 33407522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care.
    Tan NC; Goh CC; Goh SC; Koh YL; Koh KH
    J Clin Pharm Ther; 2016 Dec; 41(6):677-683. PubMed ID: 27641514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
    Ferrieres J; De Ferrari GM; Hermans MP; Elisaf M; Toth PP; Horack M; Brudi P; Lautsch D; Bash LD; Baxter CA; Ashton V; Ambegaonkar B; Gitt AK
    Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin.
    Willey VJ; Bullano MF; Shoetan NN; Gandhi SK
    Curr Med Res Opin; 2010 Jan; 26(1):121-8. PubMed ID: 19916706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy.
    Quilliam BJ; Perez HE; Andros V; Jones P
    J Manag Care Pharm; 2004; 10(3):244-50. PubMed ID: 15228375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).
    Chiang CE; Ferrières J; Gotcheva NN; Raal FJ; Shehab A; Sung J; Henriksson KM; Hermans MP
    J Atheroscler Thromb; 2016 May; 23(5):567-87. PubMed ID: 26632163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.
    Diamantopoulos EJ; Athyros VG; Yfanti GK; Migdalis EN; Elisaf M; Vardas PE; Manolis AS; Karamitsos DT; Ganotakis ES; Hatseras D;
    Angiology; 2005; 56(6):731-41. PubMed ID: 16327950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.